Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial

Desai, Akshay; Vaduganathan, Muthiah; Cleland, John; Claggett, Brian; Barkoudah, Ebrahim; Finn, Peter; McCausland, Finnian; YILMAZ, MEHMET; Lefkowitz, Martin; Shi, Victor; Pfeffer, Marc; McMurray, John; Solomon, Scott

doi:10.1161/circheartfailure.121.008597

Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial

Desai A. S., Vaduganathan M., Cleland J. G., Claggett B. L., Barkoudah E., Finn P., ...More

CIRCULATION-HEART FAILURE, vol.14, no.12, 2021 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 14 Issue: 12
Publication Date: 2021
Doi Number: 10.1161/circheartfailure.121.008597
Journal Name: CIRCULATION-HEART FAILURE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
Keywords: death, sudden, heart failure, neprilysin, valsartan
Dokuz Eylül University Affiliated: Yes

Abstract

BACKGROUND: Patients with heart failure (HF) and preserved left ventricular ejection fraction comprise a heterogeneous group including some with mildly reduced EF. We hypothesized that mode of death differs by EF in ambulatory patients with HF and preserved left ventricular ejection fraction.